Patient safety considerations regarding dermal filler injections.
Today's population is seeking procedures that enhance or improve its appearance, that require little or no downtime, and that provide immediate results. Dermal filler injections are among the top five procedures performed for this purpose. Patient safety must remain the ultimate goal of any practitioner delivering such procedures. This column will examine pertinent safety considerations in relation to the delivery of dermal filler injections.
Jones
Jill K
JK
Aesthetic Advancements, Inc., Buford, GA 30519, USA. jjones@aestheticadvancements.com
D001672:Biocompatible Materials / Q000009:adverse effects / Q000627:therapeutic use*; D002482:Cellulose / Q000627:therapeutic use; D002985:Clinical Protocols; D003094:Collagen / Q000627:therapeutic use; D003357:Cosmetic Techniques / Q000009:adverse effects / Q000451:nursing* / Q000592:standards*; D004282:Documentation / Q000592:standards; D006040:Goals; D006801:Humans; D006820:Hyaluronic Acid / Q000627:therapeutic use; D007258:Informed Consent / Q000592:standards; D007271:Injections, Intradermal; D019344:Lactic Acid / Q000627:therapeutic use; D008353:Mannitol / Q000627:therapeutic use; D008487:Medical History Taking / Q000592:standards; D024802:Nurse's Role; D010353:Patient Education as Topic / Q000592:standards; D010808:Physical Examination / Q000592:standards; D011108:Polymers / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D017751:Safety Management / Q000458:organization & administration*; D015595:Skin Aging / Q000187:drug effects; D014481:United States; D014486:United States Food and Drug Administration
D001672:Biocompatible Materials; C498114:CosmoDerm; C482305:New-Fill; D011108:Polymers; C048470:glutaraldehyde-cross-linked collagen; D019344:Lactic Acid; D008353:Mannitol; D002482:Cellulose; D006820:Hyaluronic Acid; D003094:Collagen